Dimensional Fund Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Dimensional Fund Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-314,083	Closed	-$7.8M	–	3482
2019 Q1	$7.8M	Hold	314,083	–	–	﹤0.01%	2492
2018 Q4	$5.64M	Buy	+314,083	New	+$6.42M	﹤0.01%	2570
2017 Q4	–	Sell	-40,391	Closed	-$3.33M	–	3345
2017 Q3	$3.33M	Buy	40,391 +15,525	+62%	+$1.23M	﹤0.01%	2722
2017 Q2	$2.33M	Buy	+24,866	New	+$1.52M	﹤0.01%	2821
2015 Q4	–	Sell	-31,166	Closed	-$2.87M	–	3352
2015 Q3	$2.87M	Buy	+31,166	New	+$2.7M	﹤0.01%	2711
2015 Q1	–	Sell	-220	Closed	-$12K	–	3410
2014 Q4	$12K	Sell	220 -2,223	-91%	-$117K	﹤0.01%	3448
2014 Q3	$111K	Hold	2,443	–	–	﹤0.01%	3323
2014 Q2	$101K	Hold	2,443	–	–	﹤0.01%	3377
2014 Q1	$171K	Buy	+2,443	New	+$179K	﹤0.01%	3324

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Dimensional Fund Advisors's CLVS Position: Q2 2019 in Review

Dimensional Fund Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 314,083 shares — an estimated $7.8M sold.

Dimensional Fund Advisors first reported a position in CLVS in Q1 2014 and held it in 9 quarters. The position peaked at $7.8M in Q1 2019. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

Dimensional Fund Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 314,083 Clovis Oncology, Inc. shares in Q2 2019, an estimated $7.8M.
Dimensional Fund Advisors first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 9 quarters.
Dimensional Fund Advisors's Clovis Oncology, Inc. position peaked at $7.8M in Q1 2019.
167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Dimensional Fund Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.